ACLS | Ticker Profile - Titan Protect

ACLS

Axcelis Technologies, Inc.

Technology · Semiconductor Equipment & Materials · NMS

$147.16

Data: 2026-05-28

✓ ETHICAL PASS

Unknown MOAT

HIGH

Data Confidence: 100.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$4.9B

Total market value of the company

Trailing P/E

49.04

Expensive — high growth expected

Forward P/E

34.06

Based on estimated future earnings — lower means cheaper

Rev Growth

+3.3%

Year-over-year revenue change

Profit Margin

11.9%

How much profit the company keeps from each dollar of revenue

ROE

9.7%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$173.00

+18% from current price — median analyst estimate

Recommendation

NONE

Consensus view from 3 analysts covering this stock

About Axcelis Technologies, Inc.

Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and the Asia Pacific. The company provides high energy, high current, and medium current implanters for various application requirements. It also offers aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. The company sells its equipment and services to semiconductor chip manufacturers through its direct sales force. Axcelis Technologies, Inc. was founded in 1978 and is headquartered in Beverly, Massachusetts.

https://www.axcelis.com

Country: United States Employees: 1,465 Industry: Semiconductor Equipment & Materials

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

MARKUP

Price trending up with increasing momentum

Sharpe Ratio

0.566

Good returns relative to risk taken

Kelly Fraction

0.0451

Modest edge detected — smaller position warranted

Calmar Ratio

0.241

Drawdown risk outweighs the returns — higher risk profile

Annual Return

17.5%

Historical annualised return based on price data

Max Drawdown

-72.6%

Largest peak-to-trough decline — the worst it has been

HMM State

CRISIS

Elevated risk detected — extreme caution warranted

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

1.92

Significantly more volatile than the market

52W High

$171.61

14% below the year high

52W Low

$55.93

163% above the year low

Avg Volume

718,745

Average daily shares traded — higher means easier to buy and sell

Short Ratio

3.2

Days it would take all short sellers to cover — higher means more crowded

Short % Float

12.4%

Elevated short interest — bears are positioned against this

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$3.22

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

6.75

Heavy leverage — higher financial risk if revenues decline

Current Ratio

4.59

Strong balance sheet — comfortably covers short-term obligations

Quick Ratio

2.59

Like current ratio but excludes inventory — stricter test

Gross Margin

43.6%

Revenue left after cost of goods — higher means pricing power

Operating Margin

4.0%

Profit from core operations before interest and tax

Free Cash Flow

$49M

Positive — the business generates more cash than it spends

Revenue (TTM)

$845M

Total revenue over the last 12 months

Net Income

$101M

Profitable — the bottom line is positive

Analyst Coverage

Analysts

Target High

$180.00

Target Median

$173.00

Target Low

$130.00

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go